Butylbiguanide concentration in plasma, liver, and intestine after intravenous and oral administration to man

[1]  S. Ōmura,et al.  Inhibition of Sporulation by Cerulenin and Its Reversion by Exogenous Fatty Acids in Saccharomyces cerevisiae , 1976, Antimicrobial Agents and Chemotherapy.

[2]  R. Bloch,et al.  Biochemische, histochemische, histologische und funktionelle Untersuchungen zur Phenforminwirkung auf die Dünndarmschleimhaut bei Ratte und Mensch , 1973, Klinische Wochenschrift.

[3]  D. Wingate,et al.  Effect of Phenformin on Water and Glucose Transport Across Isolated Human Ileum , 1973, Diabetes.

[4]  W. Caspary,et al.  Inhibition of intestinal amino acid transport by blood sugar lowering biguanides , 1973, Diabetologia.

[5]  E. R. Garrett,et al.  Application of ion-pair methods to drug extraction from biological fluids. II. Quantitative determination of biguanides in biological fluids and comparison of protein binding estimates. , 1972, Journal of pharmaceutical sciences.

[6]  M. Pfeffer,et al.  Intestinal sorption of anisotropine methylbromide in the rat. , 1972, Journal of pharmaceutical sciences.

[7]  W. Jusko,et al.  Effects of change in elimination on varous parameters of the two-compartment open model. , 1972, Journal of pharmaceutical sciences.

[8]  A. Bellomo,et al.  [Intravenous dimethylbiquanide and the tolbutamide test. Experimental study]. , 1972, Minerva medica.

[9]  W. Caspary,et al.  Analysis of the inhibitory effect of biguanides on glucose absorption: Inhibition of active sugar transport , 1971, Diabetologia.

[10]  R. Beckmann,et al.  Evaluation of a sustained release form of the oral antidiabetic butylbiguanide (Silubin® retard) , 1971, European Journal of Clinical Pharmacology.

[11]  U. Löhrs,et al.  [Moschcowitz-syndrome. Common synonyms: thrombotic-thrombocytic purpura; thrombohemolytic thrombocytopenic purpura, thrombotic microangiopathy]. , 1971, Die Medizinische Welt.

[12]  E. Lorch.  Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat , 1971, Diabetologia.

[13]  John G. Wagner,et al.  Biopharmaceutics and Relevant Pharmacokinetics , 1971 .

[14]  M. Gibaldi,et al.  Some considerations as to the determination and significance of biologic half-life. , 1971, Journal of pharmaceutical sciences.

[15]  R. Altschuld,et al.  Studies on the Site and Mechanism of Action of Phenformin: II. Phenformin Inhibition of Glucose Transport by Rat Intestine , 1970, Diabetes.

[16]  M. B. Rao,et al.  Studies on the Site and Mechanism of Action of Phenformin: I. Evidence for Significant “Nonperipheral” Effects of Phenformin on Glucose Metabolism in Normal Subjects , 1970, Diabetes.

[17]  A. Czyżyk.  [Impairment of intestinal glucose absorption by biguanide derivatives]. , 1969, Acta diabetologica latina.

[18]  M. Gibaldi,et al.  Relationship Between Drug Concentration in Plasma or Serum and Amount of Drug in the Body , 1969 .

[19]  A. Czyżyk,et al.  Effect of Biguanides on Intestinal Absorption of Glucose , 1968, Diabetes.

[20]  R. Beckmann.  THE FATE OF BIGUANIDES IN MAN , 1968, Annals of the New York Academy of Sciences.

[21]  Y. Yoh.  Distribution of n-butylbiguanide-14C hydrochloride in mouse tissues. , 1967, Japanese journal of pharmacology.

[22]  J. Wagner,et al.  Estimation of volume of distribution and half-life of a compound after rapid intravenous injection. , 1967, Journal of pharmaceutical sciences.

[23]  J. Ławecki,et al.  Untersuchungen über den Einflu\ von Phenyläthylbiguanid auf den Verlauf von Belastungsproben mit Insulin, Tolbutamid und Glucose bei Diabetes mellitus , 1966, Diabetologia.

[24]  W. Nelp,et al.  A METHOD FOR BETA COUNTING OF LARGE SAMPLES OF PLASMA BY LIQUID SCINTILLATION. , 1965, The Journal of laboratory and clinical medicine.

[25]  G. A. Bruno,et al.  DETERMINATION OF CARBON-14 IN AQUEOUS BICARBONATE SOLUTIONS BY LIQUID SCINTILLATION COUNTING TECHNIQUES. APPLICATION TO BIOLOGICAL FLUIDS , 1961 .

[26]  L. Biró,et al.  Die Wirkung des Phenyläthylbiguanids auf die Glucoseresorption , 1961, Klinische Wochenschrift.

[27]  R. Beckmann.  Biguanide (Experimenteller Teil) , 1971 .

[28]  Rao Mb,et al.  Studies on the site and mechanism of action of phenformin. I. Evidence for significant "nonperipheral" effects of phenformin on glucose metabolism in normal subjects. , 1970 .

[29]  L. Motta,et al.  [Study of normoglycemic activity of endovenous and oral metformin in diabetics]. , 1969, Le Diabete.

[30]  M. Rowland,et al.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment. , 1968, Journal of pharmaceutical sciences.

[31]  A. Rescigno,et al.  Drug and tracer kinetics , 1966 .